RET inhibitors for patients with RET fusion-positive and RET wild-type non-small-cell lung cancer.

Lancet Oncol

Germans Trias i Pujol Health Sciences Research Institute, Badalona, Spain; University Hospital Sagrat Cor, Barcelona, Spain.

Published: December 2016

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30557-5DOI Listing

Publication Analysis

Top Keywords

ret inhibitors
4
inhibitors patients
4
patients ret
4
ret fusion-positive
4
fusion-positive ret
4
ret wild-type
4
wild-type non-small-cell
4
non-small-cell lung
4
lung cancer
4
ret
3

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!